Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-17-001037
Filing Date
2017-02-10
Accepted
2017-02-10 18:16:17
Documents
1
Period of Report
2017-02-08

Document Format Files

Seq Description Document Type Size
1 GALENA BIOPHARMA, INC. p17-0701form4.html 4  
1 GALENA BIOPHARMA, INC. p17-0701form4.xml 4 8076
  Complete submission text file 0000902664-17-001037.txt   10451
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Reporting) CIK: 0001393825 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 17595057

Mailing Address C/O HUDSON BAY CAPITAL MANAGEMENT, L.P. 777 THIRD AVENUE, 30TH FLOOR NEW YORK NY 10017
Business Address
Gerber Sander (Reporting) CIK: 0001416593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 17595056